Predicting response to Mcl-1 targeting agents in Non-Small Cell Lung Cancer (NSCLC) and Multiple Myeloma (MM) cell lines.
Scientific Meeting Posters
Scientific Meeting Posters Summary
Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins and is frequently amplified or over-expressed in both solid tumors and hematological malignancies, suggesting that its activity may be important for the survival of cancer cells. CDK9 inhibition results in the down regulation of Mcl-1 mRNA and subsequent protein levels by inhibiting transcription and represents an indirect approach to targeting Mcl-1. Mcl-1 can also be targeted directly using an inhibitor that disrupts the Mcl-1 complexes to induce apoptosis.
To access this literature content please fill out the form below.